Macrolane a disputed HA filler for breast implantation
Macrolane is a HA gel compound which is made up of non animal hyaluronic acid, it is produced by Swedish company called Q-Med. It is very similar to Juvederm and Restylane that are commonly used in United States. Macrolane has been in UK’s market since 2008 and it was originally designed for enhancing body contouring like buttocks. Many online stores allow people to buy Macrolane from home but they must ensure that their countries’ drug safety management has allowed importation of any such filler or medicines. You can buy these products from Hyaldirect.com.
From the beginning the cosmetic community had great concerns about Macrolane, some physicians in Europe started injecting substances into the breast. The treatment was known as Boob Jab and was later promoted as “lunchtime” procedure to enlarge breast size.
The results that patients witnessed from Macrolane “Boob Jab” were quite modest, increasing about one cup size of breast. Needles were also used to inject Macolane. According to patients the results lasted about 12 months, then additional treatments are required to enlarge the breast size.
The cost of this treatment is nearly very similar to standard breast augmentation by implant. The procedure suffered great criticism as the long term results are unknown. FDA has not approved Macrolane to be used in United States, Canadian authorities have also not approved Macrolane.
We were in debate regarding concerns about using Macrolane for breast implantation from about several years ago.
Recently, Q-Med has stopped distributing Macrolane for use of breast implant in female due to lack of consensus among cosmetic community regarding cancer screening results of the breast that were treated with the product.
A survey held by British Associated of Aesthetic plastic surgeons or BAAPS member showed that one in every four surgeons is getting patients complains about complications stemming from the use of Macrolane. Additionally, a study published about a year ago warned that Macrolane can interfere with breast screening and it was also noted that patients needed corrective surgery. Time went on and finally Macrolane was withdrawn from the market which was welcomed by BAAPS
In every one of eight women it was noted that they had breast cancer. However, Macrolane use in other parts of body is still considered safe; but it should not be used in breast as breast tissues are more sensitive. If breast enlargement is required then normal breast augmentation is recommended.